Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

35.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K
Cross-reactivity00:42

Cross-reactivity

31.0K
Overview
31.0K
Master Transcription Regulators02:23

Master Transcription Regulators

6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

7.3K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.3K
RNA Polymerase II Accessory Proteins02:36

RNA Polymerase II Accessory Proteins

9.1K
Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
9.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A natural variation in rice susceptibility factor Rsf1 confers resistance to root-knot nematode.

Nature communications·2026
Same author

Differentiation of hepatocellular carcinoma from hepatic hemangioma using diffusion-derived vessel density map-based radiomics features.

Frontiers in oncology·2026
Same author

School and family based myopia education associations with myopia prevalence in Hefei high school students in the post-COVID-19 period.

Scientific reports·2026
Same author

Fusicoccane glycosides from the endophytic fungus Talaromyces sp. DC-26.

Phytochemistry·2026
Same author

The effect of perceptual training on visual quality in cataract patients with neural adaptation failure after multifocal intraocular lens implantation.

Eye (London, England)·2026
Same author

Investigation of Subcortical Deficits in Unilateral Adult Amblyopia by fMRI.

Investigative ophthalmology & visual science·2026

Related Experiment Video

Updated: Jun 4, 2025

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
09:14

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

3.8K

Identifying the key regulators orchestrating Epstein-Barr virus reactivation.

Yaohao Wang1, Jingwen Yu1, Yonggang Pei1

  • 1School of Public Health and Emergency Management, Southern University of Science and Technology, Shenzhen, Guangdong, China.

Frontiers in Microbiology
|December 20, 2024
PubMed
Summary

Epstein-Barr virus (EBV) reactivation involves complex virus-host interactions and signaling pathways. This review details critical factors, mechanisms, and novel technologies for understanding EBV reactivation and developing therapies.

Keywords:
Epstein-Barr virusimmediate-early proteinsnovel insightsreactivationregulationvirus-host interaction

More Related Videos

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

17.2K
An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
09:43

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

Published on: March 30, 2018

9.1K

Related Experiment Videos

Last Updated: Jun 4, 2025

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
09:14

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

3.8K
Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

17.2K
An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
09:43

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

Published on: March 30, 2018

9.1K

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Epstein-Barr virus (EBV) establishes lifelong infections in over 90% of the global population.
  • EBV persists through latent and lytic infection cycles, with reactivation triggered by specific conditions.
  • The intricate mechanisms governing EBV reactivation and virus-host interplay remain incompletely understood.

Purpose of the Study:

  • To review critical factors and mechanisms regulating Epstein-Barr virus reactivation.
  • To elucidate the roles of viral and host factors in EBV replication and propagation.
  • To explore novel technological applications for studying EBV reactivation and developing therapeutic strategies.

Main Methods:

  • Literature review summarizing current research on EBV reactivation.
  • Analysis of transcriptional and post-transcriptional regulation of EBV immediate-early (IE) genes.
  • Examination of viral protein functions in DNA replication, progeny production, and immune evasion.
  • Investigation of host factors influencing EBV reactivation.

Main Results:

  • EBV reactivation is regulated by complex signaling pathways and virus-host interactions.
  • Viral factors are crucial for DNA replication, progeny virus production, and disruption of host innate immunity.
  • Host factors play a significant role in modulating the reactivation process.
  • Novel technologies offer new avenues for studying EBV reactivation mechanisms.

Conclusions:

  • Understanding EBV reactivation mechanisms is crucial for controlling lifelong infections.
  • Targeting viral and host factors involved in reactivation holds therapeutic potential.
  • Advanced technologies are vital for future research into EBV pathogenesis and treatment development.